详情页 - 首都医科大学宣武医院知识库

当前位置：首页 > 详情页

Additional Biomarker Analyses from the Phase III OPTIMAL Study of First-Line Erlotinib versus Gemcitabine/Carboplatin (GC) in Chinese Patients (pts) with Advanced Activating EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE

作者：

机构： [1]Department of Medical Oncology, Jiangsu Province Cancer Hospital, China, [2]Department of Medical Oncology, Guangdong Lung Cancer Institute, Guangdong General Hospital, China, [3]Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University, China, [4]Department of Medical Oncology, Shanghai Chest Hospital, Affiliated to Shanghai Jiao Tong University, China, [5]Department of Medical Oncology, Sun Yat-Sen University Cancer Center, China, [6]Department of Medical Oncology, Xuanwu Hospital of Capital Medical University, China, [7]Department of Medical Oncology, Jilin Province Cancer Hospital, China, [8]Department of Medical Oncology, Cancer Hospital Shantou University Medical College, China, [9]Department of Medical Oncology, Hunan Province Cancer Hospital, China, [10]Department of Medical Oncology, Second Xiangya Hospital Central South University, Changsha, China

出处：

ISSN：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2009]版：

大类 | 3 区医学

小类 | 3 区呼吸系统 4 区肿瘤学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学 1 区呼吸系统

JCR分区：

出版当年[2008]版：

Q1 RESPIRATORY SYSTEM Q2 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 21.1 最新[2023版] 16.5 最新五年平均 3.508 出版当年[2008版] 3.514 出版当年五年平均 1.429 出版前一年[2007版] 4.547 出版后一年[2009版]

第一作者：

第一作者机构： [1]Department of Medical Oncology, Jiangsu Province Cancer Hospital, China,

推荐引用方式(GB/T 7714)：

APA：

MLA：